Intuitive Investments Group Plc Stock

Equities

IIG

GB00BPTH6Y20

Closed End Funds

Market Closed - London S.E. 11:35:02 2024-05-03 EDT 5-day change 1st Jan Change
130 GBX 0.00% Intraday chart for Intuitive Investments Group Plc 0.00% -5.45%

Financials

Sales 2022 -1.24M -1.55M -2.13M Sales 2023 -2.44M -3.07M -4.2M Capitalization 7.17M 8.99M 12.3M
Net income 2022 -1M -1.25M -1.72M Net income 2023 -3M -3.76M -5.15M EV / Sales 2022 -3.39 x
Net cash position 2022 1.55M 1.95M 2.67M Net cash position 2023 1.74M 2.18M 2.98M EV / Sales 2023 -2.22 x
P/E ratio 2022
-4.35 x
P/E ratio 2023
-1.91 x
Employees 5
Yield 2022 *
-
Yield 2023
-
Free-Float 26.09%
More Fundamentals * Assessed data
Dynamic Chart
1 month-10.34%
3 months+30.00%
6 months-3.70%
Current year-5.45%
More quotes
1 week
125.00
Extreme 125
132.50
1 month
115.00
Extreme 115
150.00
Current year
95.00
Extreme 95
150.00
1 year
40.00
Extreme 40
156.00
3 years
40.00
Extreme 40
242.00
5 years
40.00
Extreme 40
280.00
10 years
40.00
Extreme 40
280.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 50 20-12-07
Director of Finance/CFO 55 -
Chief Investment Officer 57 11-27
Members of the board TitleAgeSince
Chairman 76 23-08-07
Director/Board Member 74 20-06-10
Director/Board Member 57 20-12-13
More insiders
Date Price Change Volume
24-05-03 130 0.00% 6,205
24-05-02 130 0.00% 3,650
24-05-01 130 0.00% 55,721
24-04-30 130 0.00% 57,514
24-04-29 130 0.00% 7,013

Delayed Quote London S.E., May 03, 2024 at 11:35 am

More quotes
Intuitive Investments Group plc is a United Kingdom-based closed-end investment company, which is focused on the life sciences sector. The Company’s investment objective is to generate capital growth over the long term through investment in a portfolio concentrating on fast growing and/or high potential Life Sciences businesses operating predominantly in the United Kingdom, continental Europe, and the United States. The Company invests in early and late-stage life sciences businesses. It invests in the form of equity and equity-related instruments, including convertible debt instruments. The Company may acquire investments directly or by way of holdings in intermediate holding or subsidiary entities. The Company categories investment opportunities into sub-sectors in life sciences, such as diagnostics and healthcare, medical devices, tools and technologies, biotherapeutics and pharmaceuticals. Its adviser is SP Angel Corporate Finance LLP.
More about the company